DSCAM-AS1 and prostate carcinoma: The cell migration and invasion of prostate cancer were also decreased by DSCAM-AS1 knockdown (Fig. 3b, c), and the inhibitory effect was also reversed by transfection with the miR-338-3p inhibitor.